Diagnostic and Biotech

Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product (Rapid Testing Devices, Analyzers and Consumables); Sample Type (Blood, Urine, Saliva and Other Sample Types); End User (Hospitals, Diagnostic Laboratories and Forensic Laboratories) and Geography

  • THE3258802
  • 155 Pages
  • August 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The drug abuse testing market is estimated to grow with a CAGR of 5.7% from 2019-2027.

The market is driven by factors such as, increasing consumption of illicit drugs and laws and regulations related to drug abuse. However, dearth of trained laboratory professionals may limit the growth of the market to a certain extent.

Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S. As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.

Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.

Global drug abuse testing were segmented by product, sample type and end user. The product segment was categorized as rapid testing services, analyzers and consumables. On the basis of sample type, the market is segmented as urine, saliva, blood and others. Based on the end user, the drug abuse testing market is segmented into hospitals, diagnostic laboratories and forensic laboratories.

Some of the major primary and secondary sources included in the report include, Americans with Disabilities Act (ADA), The Australian Health Practitioner Regulation Agency (APHRA), The German Medical Association (BÄK), Bureau of Labor Statistics (BLS), Business Monitor International (BMI), Comprehensive Addiction and Recovery Act (CARA), Canadian Drugs and Substances Strategy (CDSS), The Drug Commission of the German Medical Association (DCGMA) and among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Drug Abuse Testing Market – By Product

1.3.2 Global Drug Abuse Testing Market – By Sample Type

1.3.3 Global Drug Abuse Testing Market – By End User

1.3.4 Global Drug Abuse Testing Market – By Geography

2. Global Drug Abuse Testing Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Drug Abuse Testing Market Landscape

4.1 Overview

4.2 Pest Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Expert Opinion

5. Global Drug Abuse Testing Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Consumption of Illicit Drugs

5.1.2 Laws and Regulations Related to Drug Abuse

5.2 Key Market Restraints

5.2.1 Dearth of Trained Laboratory Professionals

5.3 Key Market Opportunities

5.3.1 Growing Adoption of LIMS in Cannabis Testing Laboratories

5.3.2 Advances in Drug Testing Consumables:

5.4 Impact Analysis

6. Drug Abuse Testing Market – Global Analysis

6.1 Global Drug Abuse Testing Market Revenue Forecasts And Analysis

6.2 Global Drug Abuse Testing Market, By Geography - Forecasts And Analysis

6.3 Positioning Of Key Players

7. Global Drug Abuse Testing Market Analysis– by Product

7.1 Overview

7.2 Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)

7.3 Rapid Testing Devices

7.3.1 Overview

7.3.2 Rapid Testing Devices Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Analyzers

7.4.1 Overview

7.4.2 Analyzers Market Revenue and Forecast to 2027 (US$ Mn)

7.5 Consumables

7.5.1 Overview

7.5.2 Consumables Market Revenue and Forecast to 2027 (US$ Mn)

8. Global Drug Abuse Testing Market Analysis– by Sample Type

8.1 Overview

8.2 Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)

8.3 Blood

8.3.1 Overview

8.3.2 Blood Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Urine

8.4.1 Overview

8.4.2 Urine Market Revenue and Forecast to 2027 (US$ Mn)

8.5 Saliva

8.5.1 Overview

8.5.2 Saliva Market Revenue and Forecast to 2027 (US$ Mn)

8.6 Other Sample Types

8.6.1 Overview

8.6.2 Other Sample Types Market Revenue and Forecast to 2027 (US$ Mn)

9. Global Drug Abuse Testing Market Analysis– by End User

9.1 Overview

9.2 Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

9.5 Forensic Laboratories

9.5.1 Overview

9.5.2 Forensic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10. Drug Abuse Testing Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 North America Drug Abuse Testing Market Revenue And Forecasts To 2027

10.1.1 North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.4 North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5 North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.1.6 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1 US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.6.4 US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1 Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.7.4 Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.8.4 Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2 Europe Drug Abuse Testing Market Revenue And Forecasts To 2027

10.2.1 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.3 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.4 Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.5 Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.2.6 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.1 UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.2 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6.3 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.6.4 UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.7 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1 Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.7.3 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.7.4 Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1 France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.8.3 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.8.4 France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1 Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.3 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.9.4 Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.10.3 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.10.4 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027

10.3.1 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.2 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.3 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.4 Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.5 Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.3.6 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.1 Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.2 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.6.3 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.6.4 Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.7 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.1 China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.2 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.7.3 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.7.4 China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.8 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.1 India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.2 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.8.3 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.8.4 India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.9 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.1 South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.2 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.9.3 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.9.4 South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.10 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.1 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.2 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.10.3 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.10.4 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027

10.4.1 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.2 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.3 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.4.4 Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.5 Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.4.6 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.6.1 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.6.2 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

10.4.6.3 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)

10.4.6.4 UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

10.4.7 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.7.1 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.7.2 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

10.4.7.3 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)

10.4.7.4 Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

10.4.8 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.8.1 South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.8.2 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.8.3 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.4.8.4 South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5 South And Central America Drug Abuse Testing Market Revenue And Forecasts To 2027

10.5.1 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.3 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.5.4 South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.5 South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.5.6 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.1 Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.2 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.6.3 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.5.6.4 Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.7 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.1 Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.7.3 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.5.7.4 Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Drug Abuse Testing Market– Industry Landscape

11.1 Overview

11.2 Comparative Company Analysis

11.3 Growth Strategies done by the companies in the Market, (%)

11.4 Organic Developments

11.4.1 Overview

11.5 Inorganic developments

11.5.1 Overview

12. Drug Abuse Testing Market–Key company profiles

12.1 OraSure Technologies, Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 UCP Biosciences

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MEDACX Ltd.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Overview

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Beckman Coulter, Inc. (Danaher)

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Overview

12.4.4 Product Portfolio

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Alcolizer Pty Ltd.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Overview

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Wondfo

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Overview

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Redwood Toxicology LAboratory (Abbott)

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 F. Hoffmann-La Roche Ltd.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Siemens

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Information

12.9.4 Product Portfolio

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Thermo Fisher Scientific, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Information

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Drägerwerk AG & Co. KGaA

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Financial Overview

12.11.4 Product Portfolio

12.11.5 SWOT Analysis

12.11.6 Key Developments

12.12 American Screening Corporation, Inc

12.12.1 Key Facts

12.12.2 Business Description

12.12.3 Financial Overview

12.12.4 1.5.4 Product Portfolio

12.12.5 SWOT Analysis

12.12.6 Key Developments

12.13 Mercedes Medical

12.13.1 Key Facts

12.13.2 Business Description

12.13.3 Financial Overview

12.13.4 Product Portfolio

12.13.5 SWOT Analysis

12.13.6 Key Developments

12.14 Alfa Scientific Designs, Inc.

12.14.1 Key Facts

12.14.2 Business Description

12.14.3 Financial Overview

12.14.4 Product Portfolio

12.14.5 SWOT Analysis

12.14.6 Key Developments

12.15 Express Diagnostics Int'l, Inc.

12.15.1 Key Facts

12.15.2 Business Description

12.15.3 Financial Overview

12.15.4 Product Portfolio

12.15.5 SWOT Analysis

12.15.6 Key Developments

12.16 Omega Laboratories, Inc.

12.16.1 Key Facts

12.16.2 Business Description

12.16.3 Financial Overview

12.16.4 Product Portfolio

12.16.5 SWOT Analysis

12.16.6 Key Developments

12.17 Laboratorio Sodré

12.17.1 Key Facts

12.17.2 Business Description

12.17.3 Financial Overview

12.17.4 Product Portfolio

12.17.5 SWOT Analysis

12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 2. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 3. North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 4. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 5. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 6. US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 8. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 9. Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 11. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 12. Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 14. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 15. Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 17. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 18. UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 19. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 20. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 21. Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 22. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 23. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 24. France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 26. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 27. Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 28. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 29. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 30. Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 31. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 32. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 33. Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 34. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 35. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 36. Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 38. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 39. China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 40. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 41. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 42. India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 43. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 44. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 45. South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 46. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 47. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 48. Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 50. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 51. Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 52. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 53. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 54. UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 55. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 56. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 57. Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 58. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 59. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 60. South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 61. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 62. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 63. South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 64. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 65. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 66. Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 67. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 68. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 69. Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 70. Organic Developments Done By Companies

Table 71. Inorganic developments done by Companies

Table 72. Glossary of Terms, Drug Abuse Testing Market

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370